Unknown

Dataset Information

A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder.


ABSTRACT:

Objective

Clinical observations have suggested therapeutic effects for ω-3 fatty acids (O3FA) in Tourette's disorder (TD), but no randomized, controlled trials have been reported. In a placebo-controlled trial, we examined the efficacy of O3FA in children and adolescents with TD.

Methods

Thirty-three children and adolescents (ages 6-18) with TD were randomly assigned, double-blind, to O3FA or placebo for 20 weeks. O3FA consisted of combined eicosapentaenoic acid and docosahexaenoic acid. Placebo was olive oil. Groups were compared by using (1) intent-to-treat design, with the last-observation-carried-forward controlling for baseline measures and attention-deficit/hyperactivity disorder via (a) logistic regression, comparing percentage of responders on the primary Yale Global

SUBMITTER: Gabbay V 

PROVIDER: S-EPMC3362909 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature